Skip to main content

Table 2 Comparative analysis between the studied groups as regard age, sex, and anthropometric measurements

From: Pentraxin-3 in non-alcoholic fatty liver disease and its affection by concomitant chronic hepatitis C infection

Parameter

Group (Mean ± SD)

p value between three groups

p value between groups I and II

Group Ι

NAFLD patients (n = 25)

Group ΙΙ

NAFLD patients with HCV (n = 25)

Group ΙΙΙ

Healthy control (n = 20)

Age (in years)

42.7 ± 11.2

43.3 ± 9.6

42.4 ± 6.9

0.92

0.83

Sex (freq. (%))

Males

11 (44.0)

11 (44.0)

8 (40.0)

0.95

1.00

Females

14 (56.0)

14 (56.0)

12 (60.0)

Body weight (Kg)

94.8 ± 16.8

79.6 ± 10.1

69.7 ± 4.7

< 0.001a

< 0.001b

Height (cm)

167.7 ± 8.9

171.2 ± 9.8

171.3 ± 3.2

0.25

0.17

Body mass index (Kg/m2)

33.0 ± 5.1

26.7 ± 2.4

23.7 ± 1.6

< 0.001a

< 0.001b

Waist circumference (cm)

110.8 ± 15.0

98.8 ± 9.5

83.9 ± 8.0

0.003a

0.003b

  1. HCV hepatitis C virus, NAFLD nonalcoholic fatty liver disease
  2. aKruskal-Wallis test is statistically significant at 95% confidence level
  3. bMann-Whitney test is statistically significant at 95% confidence level